Skip to main content
Emily Bergsland, MD, Oncology, San Francisco, CA

Emily K. Bergsland MD


Professor, Medicine, UCSF School of Medicine

Join to View Full Profile
  • 1600 Divisadero StSan Francisco, CA 94143

  • Phone+1 415-353-9888

  • Fax+1 415-353-7150

Dr. Bergsland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)/Fresno
    University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 1995
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1990 - 1992
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 1989 - 1990
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1990 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Medical Oncology
    National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • New Multidisciplinary Approaches to Diagnosis and Palliation in Hepato-Pancreato-Biliary Tumors 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
  • Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC)(Alliance A021202). 
    2019 ASCO Annual Meeting - 6/1/2019
  • NANETS Neuroendocrine Tumor Symposium - "Emerging Targets & Therapeutic Advances in NET Management" 
    North American Neuroendocrine Tumor Society(NANETS), Charleston, South Carolina - 10/4/2013
  • Join now to see all

Press Mentions

  • The 2020 Gastrointestinal Cancers Symposium: What to Expect
    The 2020 Gastrointestinal Cancers Symposium: What to ExpectJanuary 17th, 2020
  • The Bay Area's Top Doctors of 2019
    The Bay Area's Top Doctors of 2019January 17th, 2019
  • OncLive® Hosts State of the Science Summit™: Gastrointestinal Malignancies
    OncLive® Hosts State of the Science Summit™: Gastrointestinal MalignanciesFebruary 22nd, 2018
  • Join now to see all

Grant Support

  • UCSF Paul Calabresi K12 Career Development Program in Clinical OncologyUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: